| http://dbpedia.org/ontology/abstract
|
Varlilumab (INN; development code CDX-1127 … Varlilumab (INN; development code CDX-1127) is a monoclonal antibody designed for immunotherapy for solid tumors and hematologic malignancies. It is an anti-CD27 antibody and helps activate T-cells. This drug was developed by Celldex Therapeutics. It (in combination with ONT-10) has undergone a phase 1B clinical trial for advanced breast or ovarian cancer. In combination with anti-PD-1 nivolumab it has undergone a phase 1/2 trial for advanced refractory solid tumoursrial for advanced refractory solid tumours
|
| http://dbpedia.org/ontology/casNumber
|
1393344-72-3
|
| http://dbpedia.org/ontology/fdaUniiCode
|
0125DUV5XC
|
| http://dbpedia.org/ontology/wikiPageID
|
46624845
|
| http://dbpedia.org/ontology/wikiPageLength
|
2716
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1062269038
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/CD27 +
, http://dbpedia.org/resource/International_Nonproprietary_Name +
, http://dbpedia.org/resource/Category:Monoclonal_antibodies +
, http://dbpedia.org/resource/Monoclonal_antibody +
, http://dbpedia.org/resource/Nivolumab +
, http://dbpedia.org/resource/ONT-10 +
, http://dbpedia.org/resource/T-cell_activation +
, http://dbpedia.org/resource/Immunotherapy +
|
| http://dbpedia.org/property/atcPrefix
|
none
|
| http://dbpedia.org/property/c
|
6486
|
| http://dbpedia.org/property/casNumber
|
1393344
|
| http://dbpedia.org/property/chemspiderid
|
none
|
| http://dbpedia.org/property/h
|
9992
|
| http://dbpedia.org/property/n
|
1740
|
| http://dbpedia.org/property/o
|
2022
|
| http://dbpedia.org/property/s
|
42
|
| http://dbpedia.org/property/source
|
u
|
| http://dbpedia.org/property/synonyms
|
CDX-1127
|
| http://dbpedia.org/property/target
|
http://dbpedia.org/resource/CD27 +
|
| http://dbpedia.org/property/type
|
mab
|
| http://dbpedia.org/property/unii
|
125
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Cytokine_receptor_modulators +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Monoclonals_for_immune_system +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Monoclonal-antibody-stub +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Monoclonal_antibodies +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Antibody +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Varlilumab?oldid=1062269038&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Varlilumab +
|
| owl:sameAs |
https://global.dbpedia.org/id/212xb +
, http://dbpedia.org/resource/Varlilumab +
, http://yago-knowledge.org/resource/Varlilumab +
, http://www.wikidata.org/entity/Q21098904 +
, http://rdf.freebase.com/ns/m.01370jj6 +
|
| rdf:type |
http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/ontology/MonoclonalAntibody +
|
| rdfs:comment |
Varlilumab (INN; development code CDX-1127 … Varlilumab (INN; development code CDX-1127) is a monoclonal antibody designed for immunotherapy for solid tumors and hematologic malignancies. It is an anti-CD27 antibody and helps activate T-cells. This drug was developed by Celldex Therapeutics. It (in combination with ONT-10) has undergone a phase 1B clinical trial for advanced breast or ovarian cancer. In combination with anti-PD-1 nivolumab it has undergone a phase 1/2 trial for advanced refractory solid tumoursrial for advanced refractory solid tumours
|
| rdfs:label |
Varlilumab
|
